Phase II study of chemoradiotherapy combined with gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic ductal adenocarcinoma (NUPAT 05 Trial): study protocol for a single arm phase II study

DOI: 10.18999/nagjms.81.2.233

Keywords: II study, Gemcitabine, nab-paclitaxel, chemoradiation, unresectable locally advanced pancreatic cancer

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text